Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 267.7 | 260.3 | 261.4 | 448.8 | 430.6 | 143.5 | -51.7 | 102.7 |
Revenue growth | 2.9% | -0.4% | -41.8% | 4.2% | 200.0% | -377.4% | -150.4% | -3.3% |
Cost of goods sold | 15.4 | -157.9 | 58.8 | 160.1 | 202.7 | 117.2 | -342.0 | 131.2 |
Gross profit | 252.3 | 418.2 | 202.6 | 288.6 | 227.9 | 26.3 | 290.3 | -28.5 |
Gross margin | 94.2% | 160.7% | 77.5% | 64.3% | 52.9% | 18.3% | -561.0% | -27.8% |
Research and development | 8.0 | 2.5 | 8.6 | 5.0 | 21.7 | 12.3 | 8.7 | |
General and administrative | 38.1 | 35.3 | 34.4 | 52.2 | 51.5 | 38.0 | 37.3 | 33.5 |
EBIT | 619.3 | 307.8 | 60.6 | 57.0 | -43.2 | -110.9 | -100.0 | 15.7 |
EBIT margin | 231.3% | 118.3% | 23.2% | 12.7% | -10.0% | -77.3% | 193.3% | 15.3% |
Pre-tax income | 996.0 | -64.4 | -23.9 | -75.6 | -9.3 | -118.3 | -209.2 | -211.0 |
Income taxes | -0.4 | 1.4 | 0.6 | -1.0 | 1.3 | 1.5 | -0.6 | -3.1 |
Tax rate | | | | 1.4% | | | 0.3% | 1.4% |
Earnings from continuing ops | 1,803.3 | 413.9 | -273.6 | -168.7 | -231.4 | -179.7 | -186.5 | -171.1 |
Earnings from discontinued ops | | | | -43.3 | | | | |
Net income | 1,803.3 | 413.9 | -273.6 | -212.0 | -231.4 | -179.7 | -186.5 | -171.1 |
Net margin | 673.5% | 159.0% | -104.7% | -47.2% | -53.7% | -125.2% | 360.5% | -166.7% |
|
Diluted EPS | $16.61 | $3.77 | ($2.80) | ($1.68) | ($2.30) | ($1.79) | ($1.99) | ($1.83) |
Shares outstanding (diluted) | 108.5 | 109.6 | 97.6 | 100.7 | 100.7 | 100.6 | 93.9 | 93.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|